nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—HTR2A—Alzheimer's disease	0.152	0.522	CbGaD
Paliperidone—CYP2D6—Alzheimer's disease	0.139	0.478	CbGaD
Paliperidone—HTR2A—Donepezil—Alzheimer's disease	0.106	0.296	CbGbCtD
Paliperidone—DRD2—Memantine—Alzheimer's disease	0.0843	0.237	CbGbCtD
Paliperidone—CYP2D6—Rivastigmine—Alzheimer's disease	0.0439	0.123	CbGbCtD
Paliperidone—CYP2D6—Donepezil—Alzheimer's disease	0.0351	0.0986	CbGbCtD
Paliperidone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0279	0.0784	CbGbCtD
Paliperidone—CYP2D6—Galantamine—Alzheimer's disease	0.0226	0.0635	CbGbCtD
Paliperidone—CYP3A4—Donepezil—Alzheimer's disease	0.0223	0.0627	CbGbCtD
Paliperidone—CYP3A4—Galantamine—Alzheimer's disease	0.0144	0.0404	CbGbCtD
Paliperidone—HTR2C—choroid plexus—Alzheimer's disease	0.00899	0.125	CbGeAlD
Paliperidone—DRD3—telencephalic ventricle—Alzheimer's disease	0.00473	0.0659	CbGeAlD
Paliperidone—HTR2A—choroid plexus—Alzheimer's disease	0.00451	0.0627	CbGeAlD
Paliperidone—DRD1—telencephalic ventricle—Alzheimer's disease	0.00339	0.0472	CbGeAlD
Paliperidone—HTR2A—locus ceruleus—Alzheimer's disease	0.00279	0.0388	CbGeAlD
Paliperidone—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00275	0.0382	CbGeAlD
Paliperidone—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00266	0.037	CbGeAlD
Paliperidone—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00263	0.0366	CbGeAlD
Paliperidone—HTR2A—cerebellar cortex—Alzheimer's disease	0.00227	0.0316	CbGeAlD
Paliperidone—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00222	0.0308	CbGeAlD
Paliperidone—DRD2—telencephalic ventricle—Alzheimer's disease	0.002	0.0279	CbGeAlD
Paliperidone—Iloperidone—HTR6—Alzheimer's disease	0.0015	0.462	CrCbGaD
Paliperidone—HTR1B—blood vessel—Alzheimer's disease	0.00136	0.0189	CbGeAlD
Paliperidone—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00132	0.0184	CbGeAlD
Paliperidone—HTR1D—blood vessel—Alzheimer's disease	0.00132	0.0183	CbGeAlD
Paliperidone—DRD1—forebrain—Alzheimer's disease	0.000885	0.0123	CbGeAlD
Paliperidone—DRD1—telencephalon—Alzheimer's disease	0.000814	0.0113	CbGeAlD
Paliperidone—DRD4—brain—Alzheimer's disease	0.00073	0.0102	CbGeAlD
Paliperidone—HTR1B—forebrain—Alzheimer's disease	0.000717	0.00998	CbGeAlD
Paliperidone—HTR1D—forebrain—Alzheimer's disease	0.000695	0.00966	CbGeAlD
Paliperidone—HTR2C—forebrain—Alzheimer's disease	0.000688	0.00957	CbGeAlD
Paliperidone—DRD3—nervous system—Alzheimer's disease	0.000671	0.00934	CbGeAlD
Paliperidone—HTR1B—telencephalon—Alzheimer's disease	0.00066	0.00918	CbGeAlD
Paliperidone—HTR2A—blood vessel—Alzheimer's disease	0.000654	0.0091	CbGeAlD
Paliperidone—DRD3—central nervous system—Alzheimer's disease	0.000646	0.00899	CbGeAlD
Paliperidone—HTR1D—telencephalon—Alzheimer's disease	0.000639	0.00888	CbGeAlD
Paliperidone—HTR2C—telencephalon—Alzheimer's disease	0.000632	0.0088	CbGeAlD
Paliperidone—HTR1A—forebrain—Alzheimer's disease	0.000579	0.00805	CbGeAlD
Paliperidone—ADRA1A—forebrain—Alzheimer's disease	0.000534	0.00742	CbGeAlD
Paliperidone—HTR1A—telencephalon—Alzheimer's disease	0.000532	0.00741	CbGeAlD
Paliperidone—DRD2—forebrain—Alzheimer's disease	0.000523	0.00728	CbGeAlD
Paliperidone—ADRA1B—nervous system—Alzheimer's disease	0.000516	0.00717	CbGeAlD
Paliperidone—DRD3—brain—Alzheimer's disease	0.000513	0.00714	CbGeAlD
Paliperidone—ADRA1B—central nervous system—Alzheimer's disease	0.000496	0.00691	CbGeAlD
Paliperidone—ADRA1A—telencephalon—Alzheimer's disease	0.000491	0.00683	CbGeAlD
Paliperidone—DRD2—telencephalon—Alzheimer's disease	0.000481	0.00669	CbGeAlD
Paliperidone—DRD1—nervous system—Alzheimer's disease	0.000481	0.00669	CbGeAlD
Paliperidone—Risperidone—HTR2A—Alzheimer's disease	0.000469	0.145	CrCbGaD
Paliperidone—ADRA2C—telencephalon—Alzheimer's disease	0.000468	0.0065	CbGeAlD
Paliperidone—DRD1—central nervous system—Alzheimer's disease	0.000463	0.00644	CbGeAlD
Paliperidone—Iloperidone—HTR2A—Alzheimer's disease	0.00044	0.136	CrCbGaD
Paliperidone—Risperidone—CYP2D6—Alzheimer's disease	0.000429	0.133	CrCbGaD
Paliperidone—HRH1—forebrain—Alzheimer's disease	0.000413	0.00575	CbGeAlD
Paliperidone—ADRA2A—forebrain—Alzheimer's disease	0.000406	0.00564	CbGeAlD
Paliperidone—Iloperidone—CYP2D6—Alzheimer's disease	0.000403	0.124	CrCbGaD
Paliperidone—ADRA1B—brain—Alzheimer's disease	0.000394	0.00548	CbGeAlD
Paliperidone—HTR2A—embryo—Alzheimer's disease	0.00039	0.00543	CbGeAlD
Paliperidone—HTR1B—nervous system—Alzheimer's disease	0.000389	0.00542	CbGeAlD
Paliperidone—HRH1—telencephalon—Alzheimer's disease	0.00038	0.00528	CbGeAlD
Paliperidone—HTR1D—nervous system—Alzheimer's disease	0.000377	0.00524	CbGeAlD
Paliperidone—HTR1B—central nervous system—Alzheimer's disease	0.000375	0.00522	CbGeAlD
Paliperidone—HTR2C—nervous system—Alzheimer's disease	0.000373	0.00519	CbGeAlD
Paliperidone—ADRA2A—telencephalon—Alzheimer's disease	0.000373	0.00519	CbGeAlD
Paliperidone—DRD1—brain—Alzheimer's disease	0.000367	0.00511	CbGeAlD
Paliperidone—HTR1D—central nervous system—Alzheimer's disease	0.000363	0.00505	CbGeAlD
Paliperidone—HTR2C—central nervous system—Alzheimer's disease	0.000359	0.005	CbGeAlD
Paliperidone—HTR2A—forebrain—Alzheimer's disease	0.000345	0.0048	CbGeAlD
Paliperidone—HTR2A—telencephalon—Alzheimer's disease	0.000317	0.00441	CbGeAlD
Paliperidone—CYP2D6—forebrain—Alzheimer's disease	0.000314	0.00437	CbGeAlD
Paliperidone—HTR1A—nervous system—Alzheimer's disease	0.000314	0.00437	CbGeAlD
Paliperidone—HTR1A—central nervous system—Alzheimer's disease	0.000303	0.00421	CbGeAlD
Paliperidone—HTR1B—brain—Alzheimer's disease	0.000298	0.00414	CbGeAlD
Paliperidone—HTR1A—cerebellum—Alzheimer's disease	0.000296	0.00411	CbGeAlD
Paliperidone—ADRA1A—nervous system—Alzheimer's disease	0.00029	0.00403	CbGeAlD
Paliperidone—CYP2D6—telencephalon—Alzheimer's disease	0.000289	0.00402	CbGeAlD
Paliperidone—HTR1D—brain—Alzheimer's disease	0.000288	0.00401	CbGeAlD
Paliperidone—HTR2C—brain—Alzheimer's disease	0.000285	0.00397	CbGeAlD
Paliperidone—DRD2—nervous system—Alzheimer's disease	0.000284	0.00395	CbGeAlD
Paliperidone—ADRA1A—central nervous system—Alzheimer's disease	0.000279	0.00388	CbGeAlD
Paliperidone—ADRA2C—nervous system—Alzheimer's disease	0.000276	0.00384	CbGeAlD
Paliperidone—DRD2—central nervous system—Alzheimer's disease	0.000273	0.0038	CbGeAlD
Paliperidone—ADRA1A—cerebellum—Alzheimer's disease	0.000273	0.00379	CbGeAlD
Paliperidone—DRD2—cerebellum—Alzheimer's disease	0.000267	0.00372	CbGeAlD
Paliperidone—ADRA2C—central nervous system—Alzheimer's disease	0.000266	0.0037	CbGeAlD
Paliperidone—ADRA2C—cerebellum—Alzheimer's disease	0.00026	0.00361	CbGeAlD
Paliperidone—HTR1A—brain—Alzheimer's disease	0.00024	0.00334	CbGeAlD
Paliperidone—HRH1—nervous system—Alzheimer's disease	0.000224	0.00312	CbGeAlD
Paliperidone—ADRA1A—brain—Alzheimer's disease	0.000221	0.00308	CbGeAlD
Paliperidone—ADRA2A—nervous system—Alzheimer's disease	0.00022	0.00306	CbGeAlD
Paliperidone—DRD2—brain—Alzheimer's disease	0.000217	0.00302	CbGeAlD
Paliperidone—HRH1—central nervous system—Alzheimer's disease	0.000216	0.003	CbGeAlD
Paliperidone—ADRA2A—central nervous system—Alzheimer's disease	0.000212	0.00295	CbGeAlD
Paliperidone—ADRA2C—brain—Alzheimer's disease	0.000211	0.00294	CbGeAlD
Paliperidone—ADRA2A—cerebellum—Alzheimer's disease	0.000207	0.00288	CbGeAlD
Paliperidone—HTR2A—nervous system—Alzheimer's disease	0.000187	0.00261	CbGeAlD
Paliperidone—HTR2A—central nervous system—Alzheimer's disease	0.00018	0.00251	CbGeAlD
Paliperidone—HTR2A—cerebellum—Alzheimer's disease	0.000176	0.00245	CbGeAlD
Paliperidone—Rhinitis—Memantine—Alzheimer's disease	0.000175	0.000868	CcSEcCtD
Paliperidone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000173	0.000862	CcSEcCtD
Paliperidone—CYP3A4—nervous system—Alzheimer's disease	0.000173	0.00241	CbGeAlD
Paliperidone—Hypoaesthesia—Memantine—Alzheimer's disease	0.000173	0.000861	CcSEcCtD
Paliperidone—Shock—Galantamine—Alzheimer's disease	0.000173	0.00086	CcSEcCtD
Paliperidone—Nervous system disorder—Galantamine—Alzheimer's disease	0.000172	0.000857	CcSEcCtD
Paliperidone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000172	0.000856	CcSEcCtD
Paliperidone—Chills—Donepezil—Alzheimer's disease	0.000172	0.000856	CcSEcCtD
Paliperidone—Urinary tract disorder—Memantine—Alzheimer's disease	0.000172	0.000855	CcSEcCtD
Paliperidone—Tachycardia—Galantamine—Alzheimer's disease	0.000172	0.000853	CcSEcCtD
Paliperidone—Oedema peripheral—Memantine—Alzheimer's disease	0.000172	0.000853	CcSEcCtD
Paliperidone—HRH1—brain—Alzheimer's disease	0.000171	0.00238	CbGeAlD
Paliperidone—Connective tissue disorder—Memantine—Alzheimer's disease	0.000171	0.000851	CcSEcCtD
Paliperidone—Rhinitis—Rivastigmine—Alzheimer's disease	0.000171	0.000849	CcSEcCtD
Paliperidone—Skin disorder—Galantamine—Alzheimer's disease	0.000171	0.000849	CcSEcCtD
Paliperidone—Urethral disorder—Memantine—Alzheimer's disease	0.000171	0.000849	CcSEcCtD
Paliperidone—CYP2D6—nervous system—Alzheimer's disease	0.000171	0.00237	CbGeAlD
Paliperidone—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00017	0.000843	CcSEcCtD
Paliperidone—Alopecia—Donepezil—Alzheimer's disease	0.00017	0.000843	CcSEcCtD
Paliperidone—ADRA2A—brain—Alzheimer's disease	0.000168	0.00234	CbGeAlD
Paliperidone—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000168	0.000836	CcSEcCtD
Paliperidone—Mental disorder—Donepezil—Alzheimer's disease	0.000168	0.000835	CcSEcCtD
Paliperidone—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000168	0.000834	CcSEcCtD
Paliperidone—Anorexia—Galantamine—Alzheimer's disease	0.000168	0.000833	CcSEcCtD
Paliperidone—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000167	0.000832	CcSEcCtD
Paliperidone—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000167	0.00083	CcSEcCtD
Paliperidone—Erythema—Donepezil—Alzheimer's disease	0.000167	0.00083	CcSEcCtD
Paliperidone—Malnutrition—Donepezil—Alzheimer's disease	0.000167	0.00083	CcSEcCtD
Paliperidone—CYP3A4—central nervous system—Alzheimer's disease	0.000167	0.00232	CbGeAlD
Paliperidone—Flatulence—Donepezil—Alzheimer's disease	0.000165	0.000818	CcSEcCtD
Paliperidone—Hypotension—Galantamine—Alzheimer's disease	0.000164	0.000817	CcSEcCtD
Paliperidone—CYP2D6—central nervous system—Alzheimer's disease	0.000164	0.00229	CbGeAlD
Paliperidone—Tension—Donepezil—Alzheimer's disease	0.000164	0.000815	CcSEcCtD
Paliperidone—Dysgeusia—Donepezil—Alzheimer's disease	0.000164	0.000813	CcSEcCtD
Paliperidone—Eye disorder—Memantine—Alzheimer's disease	0.000163	0.000809	CcSEcCtD
Paliperidone—Tinnitus—Memantine—Alzheimer's disease	0.000162	0.000807	CcSEcCtD
Paliperidone—Nervousness—Donepezil—Alzheimer's disease	0.000162	0.000806	CcSEcCtD
Paliperidone—Flushing—Memantine—Alzheimer's disease	0.000162	0.000804	CcSEcCtD
Paliperidone—Cardiac disorder—Memantine—Alzheimer's disease	0.000162	0.000804	CcSEcCtD
Paliperidone—Back pain—Donepezil—Alzheimer's disease	0.000162	0.000803	CcSEcCtD
Paliperidone—CYP2D6—cerebellum—Alzheimer's disease	0.000161	0.00223	CbGeAlD
Paliperidone—Muscle spasms—Donepezil—Alzheimer's disease	0.000161	0.000798	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00016	0.000796	CcSEcCtD
Paliperidone—Eye disorder—Rivastigmine—Alzheimer's disease	0.000159	0.000792	CcSEcCtD
Paliperidone—Insomnia—Galantamine—Alzheimer's disease	0.000159	0.000791	CcSEcCtD
Paliperidone—Tinnitus—Rivastigmine—Alzheimer's disease	0.000159	0.00079	CcSEcCtD
Paliperidone—Flushing—Rivastigmine—Alzheimer's disease	0.000158	0.000786	CcSEcCtD
Paliperidone—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000158	0.000786	CcSEcCtD
Paliperidone—Angiopathy—Memantine—Alzheimer's disease	0.000158	0.000786	CcSEcCtD
Paliperidone—Paraesthesia—Galantamine—Alzheimer's disease	0.000158	0.000785	CcSEcCtD
Paliperidone—Vision blurred—Donepezil—Alzheimer's disease	0.000157	0.000782	CcSEcCtD
Paliperidone—Immune system disorder—Memantine—Alzheimer's disease	0.000157	0.000782	CcSEcCtD
Paliperidone—Mediastinal disorder—Memantine—Alzheimer's disease	0.000157	0.00078	CcSEcCtD
Paliperidone—Tremor—Donepezil—Alzheimer's disease	0.000156	0.000778	CcSEcCtD
Paliperidone—Somnolence—Galantamine—Alzheimer's disease	0.000156	0.000777	CcSEcCtD
Paliperidone—Chills—Memantine—Alzheimer's disease	0.000156	0.000777	CcSEcCtD
Paliperidone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000155	0.00077	CcSEcCtD
Paliperidone—Dyspepsia—Galantamine—Alzheimer's disease	0.000155	0.00077	CcSEcCtD
Paliperidone—Angiopathy—Rivastigmine—Alzheimer's disease	0.000155	0.000768	CcSEcCtD
Paliperidone—Anaemia—Donepezil—Alzheimer's disease	0.000154	0.000767	CcSEcCtD
Paliperidone—Alopecia—Memantine—Alzheimer's disease	0.000154	0.000765	CcSEcCtD
Paliperidone—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000154	0.000763	CcSEcCtD
Paliperidone—Agitation—Donepezil—Alzheimer's disease	0.000153	0.000763	CcSEcCtD
Paliperidone—Chills—Rivastigmine—Alzheimer's disease	0.000153	0.00076	CcSEcCtD
Paliperidone—Decreased appetite—Galantamine—Alzheimer's disease	0.000153	0.00076	CcSEcCtD
Paliperidone—Mental disorder—Memantine—Alzheimer's disease	0.000153	0.000759	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000152	0.000755	CcSEcCtD
Paliperidone—Malnutrition—Memantine—Alzheimer's disease	0.000152	0.000754	CcSEcCtD
Paliperidone—Fatigue—Galantamine—Alzheimer's disease	0.000152	0.000754	CcSEcCtD
Paliperidone—Malaise—Donepezil—Alzheimer's disease	0.000151	0.000749	CcSEcCtD
Paliperidone—Alopecia—Rivastigmine—Alzheimer's disease	0.000151	0.000748	CcSEcCtD
Paliperidone—Constipation—Galantamine—Alzheimer's disease	0.00015	0.000748	CcSEcCtD
Paliperidone—Vertigo—Donepezil—Alzheimer's disease	0.00015	0.000746	CcSEcCtD
Paliperidone—Syncope—Donepezil—Alzheimer's disease	0.00015	0.000744	CcSEcCtD
Paliperidone—Flatulence—Memantine—Alzheimer's disease	0.000149	0.000743	CcSEcCtD
Paliperidone—Mental disorder—Rivastigmine—Alzheimer's disease	0.000149	0.000742	CcSEcCtD
Paliperidone—Tension—Memantine—Alzheimer's disease	0.000149	0.00074	CcSEcCtD
Paliperidone—Dysgeusia—Memantine—Alzheimer's disease	0.000148	0.000738	CcSEcCtD
Paliperidone—Malnutrition—Rivastigmine—Alzheimer's disease	0.000148	0.000737	CcSEcCtD
Paliperidone—Erythema—Rivastigmine—Alzheimer's disease	0.000148	0.000737	CcSEcCtD
Paliperidone—Nervousness—Memantine—Alzheimer's disease	0.000147	0.000732	CcSEcCtD
Paliperidone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000147	0.00073	CcSEcCtD
Paliperidone—Back pain—Memantine—Alzheimer's disease	0.000147	0.000729	CcSEcCtD
Paliperidone—Flatulence—Rivastigmine—Alzheimer's disease	0.000146	0.000727	CcSEcCtD
Paliperidone—Cough—Donepezil—Alzheimer's disease	0.000146	0.000724	CcSEcCtD
Paliperidone—Tension—Rivastigmine—Alzheimer's disease	0.000146	0.000724	CcSEcCtD
Paliperidone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000145	0.000722	CcSEcCtD
Paliperidone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000145	0.00072	CcSEcCtD
Paliperidone—Convulsion—Donepezil—Alzheimer's disease	0.000145	0.000719	CcSEcCtD
Paliperidone—Hypertension—Donepezil—Alzheimer's disease	0.000144	0.000717	CcSEcCtD
Paliperidone—Nervousness—Rivastigmine—Alzheimer's disease	0.000144	0.000716	CcSEcCtD
Paliperidone—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000144	0.000715	CcSEcCtD
Paliperidone—Back pain—Rivastigmine—Alzheimer's disease	0.000143	0.000713	CcSEcCtD
Paliperidone—HTR2A—brain—Alzheimer's disease	0.000143	0.00199	CbGeAlD
Paliperidone—Vision blurred—Memantine—Alzheimer's disease	0.000143	0.00071	CcSEcCtD
Paliperidone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000143	0.000709	CcSEcCtD
Paliperidone—Arthralgia—Donepezil—Alzheimer's disease	0.000142	0.000707	CcSEcCtD
Paliperidone—Myalgia—Donepezil—Alzheimer's disease	0.000142	0.000707	CcSEcCtD
Paliperidone—Chest pain—Donepezil—Alzheimer's disease	0.000142	0.000707	CcSEcCtD
Paliperidone—Tremor—Memantine—Alzheimer's disease	0.000142	0.000706	CcSEcCtD
Paliperidone—Anxiety—Donepezil—Alzheimer's disease	0.000142	0.000704	CcSEcCtD
Paliperidone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000141	0.000699	CcSEcCtD
Paliperidone—Discomfort—Donepezil—Alzheimer's disease	0.00014	0.000698	CcSEcCtD
Paliperidone—Anaemia—Memantine—Alzheimer's disease	0.00014	0.000697	CcSEcCtD
Paliperidone—Vision blurred—Rivastigmine—Alzheimer's disease	0.00014	0.000695	CcSEcCtD
Paliperidone—Agitation—Memantine—Alzheimer's disease	0.000139	0.000693	CcSEcCtD
Paliperidone—Dry mouth—Donepezil—Alzheimer's disease	0.000139	0.000691	CcSEcCtD
Paliperidone—Body temperature increased—Galantamine—Alzheimer's disease	0.000139	0.000691	CcSEcCtD
Paliperidone—Abdominal pain—Galantamine—Alzheimer's disease	0.000139	0.000691	CcSEcCtD
Paliperidone—Tremor—Rivastigmine—Alzheimer's disease	0.000139	0.000691	CcSEcCtD
Paliperidone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000138	0.000684	CcSEcCtD
Paliperidone—Confusional state—Donepezil—Alzheimer's disease	0.000137	0.000683	CcSEcCtD
Paliperidone—Anaemia—Rivastigmine—Alzheimer's disease	0.000137	0.000682	CcSEcCtD
Paliperidone—Malaise—Memantine—Alzheimer's disease	0.000137	0.00068	CcSEcCtD
Paliperidone—Agitation—Rivastigmine—Alzheimer's disease	0.000136	0.000678	CcSEcCtD
Paliperidone—Oedema—Donepezil—Alzheimer's disease	0.000136	0.000677	CcSEcCtD
Paliperidone—Vertigo—Memantine—Alzheimer's disease	0.000136	0.000677	CcSEcCtD
Paliperidone—Syncope—Memantine—Alzheimer's disease	0.000136	0.000676	CcSEcCtD
Paliperidone—Leukopenia—Memantine—Alzheimer's disease	0.000136	0.000675	CcSEcCtD
Paliperidone—Infection—Donepezil—Alzheimer's disease	0.000135	0.000673	CcSEcCtD
Paliperidone—Shock—Donepezil—Alzheimer's disease	0.000134	0.000667	CcSEcCtD
Paliperidone—Palpitations—Memantine—Alzheimer's disease	0.000134	0.000666	CcSEcCtD
Paliperidone—Malaise—Rivastigmine—Alzheimer's disease	0.000134	0.000665	CcSEcCtD
Paliperidone—Nervous system disorder—Donepezil—Alzheimer's disease	0.000134	0.000664	CcSEcCtD
Paliperidone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000133	0.000663	CcSEcCtD
Paliperidone—Vertigo—Rivastigmine—Alzheimer's disease	0.000133	0.000662	CcSEcCtD
Paliperidone—Loss of consciousness—Memantine—Alzheimer's disease	0.000133	0.000662	CcSEcCtD
Paliperidone—Syncope—Rivastigmine—Alzheimer's disease	0.000133	0.000661	CcSEcCtD
Paliperidone—Cough—Memantine—Alzheimer's disease	0.000132	0.000658	CcSEcCtD
Paliperidone—Convulsion—Memantine—Alzheimer's disease	0.000131	0.000653	CcSEcCtD
Paliperidone—Palpitations—Rivastigmine—Alzheimer's disease	0.000131	0.000652	CcSEcCtD
Paliperidone—Hypertension—Memantine—Alzheimer's disease	0.000131	0.000651	CcSEcCtD
Paliperidone—CYP2D6—brain—Alzheimer's disease	0.00013	0.00181	CbGeAlD
Paliperidone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00013	0.000648	CcSEcCtD
Paliperidone—Anorexia—Donepezil—Alzheimer's disease	0.00013	0.000646	CcSEcCtD
Paliperidone—Hypersensitivity—Galantamine—Alzheimer's disease	0.00013	0.000644	CcSEcCtD
Paliperidone—Cough—Rivastigmine—Alzheimer's disease	0.000129	0.000643	CcSEcCtD
Paliperidone—Myalgia—Memantine—Alzheimer's disease	0.000129	0.000642	CcSEcCtD
Paliperidone—Chest pain—Memantine—Alzheimer's disease	0.000129	0.000642	CcSEcCtD
Paliperidone—Arthralgia—Memantine—Alzheimer's disease	0.000129	0.000642	CcSEcCtD
Paliperidone—Anxiety—Memantine—Alzheimer's disease	0.000129	0.000639	CcSEcCtD
Paliperidone—Convulsion—Rivastigmine—Alzheimer's disease	0.000129	0.000639	CcSEcCtD
Paliperidone—Hypertension—Rivastigmine—Alzheimer's disease	0.000128	0.000637	CcSEcCtD
Paliperidone—Discomfort—Memantine—Alzheimer's disease	0.000128	0.000634	CcSEcCtD
Paliperidone—Hypotension—Donepezil—Alzheimer's disease	0.000127	0.000633	CcSEcCtD
Paliperidone—Myalgia—Rivastigmine—Alzheimer's disease	0.000126	0.000628	CcSEcCtD
Paliperidone—Arthralgia—Rivastigmine—Alzheimer's disease	0.000126	0.000628	CcSEcCtD
Paliperidone—Chest pain—Rivastigmine—Alzheimer's disease	0.000126	0.000628	CcSEcCtD
Paliperidone—Dry mouth—Memantine—Alzheimer's disease	0.000126	0.000628	CcSEcCtD
Paliperidone—Asthenia—Galantamine—Alzheimer's disease	0.000126	0.000627	CcSEcCtD
Paliperidone—Anxiety—Rivastigmine—Alzheimer's disease	0.000126	0.000626	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000125	0.000623	CcSEcCtD
Paliperidone—Confusional state—Memantine—Alzheimer's disease	0.000125	0.00062	CcSEcCtD
Paliperidone—Discomfort—Rivastigmine—Alzheimer's disease	0.000125	0.00062	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000124	0.000617	CcSEcCtD
Paliperidone—Oedema—Memantine—Alzheimer's disease	0.000124	0.000615	CcSEcCtD
Paliperidone—Dry mouth—Rivastigmine—Alzheimer's disease	0.000124	0.000614	CcSEcCtD
Paliperidone—Insomnia—Donepezil—Alzheimer's disease	0.000123	0.000613	CcSEcCtD
Paliperidone—Infection—Memantine—Alzheimer's disease	0.000123	0.000611	CcSEcCtD
Paliperidone—Paraesthesia—Donepezil—Alzheimer's disease	0.000122	0.000608	CcSEcCtD
Paliperidone—Confusional state—Rivastigmine—Alzheimer's disease	0.000122	0.000607	CcSEcCtD
Paliperidone—Shock—Memantine—Alzheimer's disease	0.000122	0.000605	CcSEcCtD
Paliperidone—Dyspnoea—Donepezil—Alzheimer's disease	0.000122	0.000604	CcSEcCtD
Paliperidone—Nervous system disorder—Memantine—Alzheimer's disease	0.000121	0.000603	CcSEcCtD
Paliperidone—Somnolence—Donepezil—Alzheimer's disease	0.000121	0.000602	CcSEcCtD
Paliperidone—Thrombocytopenia—Memantine—Alzheimer's disease	0.000121	0.000602	CcSEcCtD
Paliperidone—Oedema—Rivastigmine—Alzheimer's disease	0.000121	0.000602	CcSEcCtD
Paliperidone—Tachycardia—Memantine—Alzheimer's disease	0.000121	0.0006	CcSEcCtD
Paliperidone—Diarrhoea—Galantamine—Alzheimer's disease	0.00012	0.000598	CcSEcCtD
Paliperidone—Infection—Rivastigmine—Alzheimer's disease	0.00012	0.000598	CcSEcCtD
Paliperidone—Skin disorder—Memantine—Alzheimer's disease	0.00012	0.000598	CcSEcCtD
Paliperidone—Dyspepsia—Donepezil—Alzheimer's disease	0.00012	0.000596	CcSEcCtD
Paliperidone—Shock—Rivastigmine—Alzheimer's disease	0.000119	0.000592	CcSEcCtD
Paliperidone—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000119	0.00059	CcSEcCtD
Paliperidone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000119	0.000589	CcSEcCtD
Paliperidone—Decreased appetite—Donepezil—Alzheimer's disease	0.000118	0.000589	CcSEcCtD
Paliperidone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000118	0.000587	CcSEcCtD
Paliperidone—Anorexia—Memantine—Alzheimer's disease	0.000118	0.000586	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000118	0.000585	CcSEcCtD
Paliperidone—Skin disorder—Rivastigmine—Alzheimer's disease	0.000118	0.000585	CcSEcCtD
Paliperidone—Fatigue—Donepezil—Alzheimer's disease	0.000117	0.000584	CcSEcCtD
Paliperidone—Pain—Donepezil—Alzheimer's disease	0.000117	0.000579	CcSEcCtD
Paliperidone—Constipation—Donepezil—Alzheimer's disease	0.000117	0.000579	CcSEcCtD
Paliperidone—Dizziness—Galantamine—Alzheimer's disease	0.000116	0.000578	CcSEcCtD
Paliperidone—Hypotension—Memantine—Alzheimer's disease	0.000116	0.000575	CcSEcCtD
Paliperidone—Anorexia—Rivastigmine—Alzheimer's disease	0.000115	0.000574	CcSEcCtD
Paliperidone—Hypotension—Rivastigmine—Alzheimer's disease	0.000113	0.000562	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000113	0.00056	CcSEcCtD
Paliperidone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000112	0.000558	CcSEcCtD
Paliperidone—Insomnia—Memantine—Alzheimer's disease	0.000112	0.000556	CcSEcCtD
Paliperidone—Vomiting—Galantamine—Alzheimer's disease	0.000112	0.000556	CcSEcCtD
Paliperidone—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000111	0.000554	CcSEcCtD
Paliperidone—Paraesthesia—Memantine—Alzheimer's disease	0.000111	0.000552	CcSEcCtD
Paliperidone—Rash—Galantamine—Alzheimer's disease	0.000111	0.000551	CcSEcCtD
Paliperidone—Dermatitis—Galantamine—Alzheimer's disease	0.000111	0.000551	CcSEcCtD
Paliperidone—Dyspnoea—Memantine—Alzheimer's disease	0.00011	0.000548	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00011	0.000548	CcSEcCtD
Paliperidone—Headache—Galantamine—Alzheimer's disease	0.00011	0.000548	CcSEcCtD
Paliperidone—Somnolence—Memantine—Alzheimer's disease	0.00011	0.000547	CcSEcCtD
Paliperidone—Insomnia—Rivastigmine—Alzheimer's disease	0.000109	0.000544	CcSEcCtD
Paliperidone—Dyspepsia—Memantine—Alzheimer's disease	0.000109	0.000541	CcSEcCtD
Paliperidone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000109	0.00054	CcSEcCtD
Paliperidone—Urticaria—Donepezil—Alzheimer's disease	0.000108	0.000538	CcSEcCtD
Paliperidone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000108	0.000537	CcSEcCtD
Paliperidone—Abdominal pain—Donepezil—Alzheimer's disease	0.000108	0.000536	CcSEcCtD
Paliperidone—Body temperature increased—Donepezil—Alzheimer's disease	0.000108	0.000536	CcSEcCtD
Paliperidone—Somnolence—Rivastigmine—Alzheimer's disease	0.000108	0.000535	CcSEcCtD
Paliperidone—Decreased appetite—Memantine—Alzheimer's disease	0.000108	0.000535	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000107	0.000531	CcSEcCtD
Paliperidone—Fatigue—Memantine—Alzheimer's disease	0.000107	0.00053	CcSEcCtD
Paliperidone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000107	0.00053	CcSEcCtD
Paliperidone—Pain—Memantine—Alzheimer's disease	0.000106	0.000526	CcSEcCtD
Paliperidone—Constipation—Memantine—Alzheimer's disease	0.000106	0.000526	CcSEcCtD
Paliperidone—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000105	0.000523	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000105	0.00052	CcSEcCtD
Paliperidone—Nausea—Galantamine—Alzheimer's disease	0.000104	0.000519	CcSEcCtD
Paliperidone—Fatigue—Rivastigmine—Alzheimer's disease	0.000104	0.000519	CcSEcCtD
Paliperidone—Pain—Rivastigmine—Alzheimer's disease	0.000104	0.000515	CcSEcCtD
Paliperidone—Constipation—Rivastigmine—Alzheimer's disease	0.000104	0.000515	CcSEcCtD
Paliperidone—Feeling abnormal—Memantine—Alzheimer's disease	0.000102	0.000507	CcSEcCtD
Paliperidone—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000101	0.000503	CcSEcCtD
Paliperidone—Hypersensitivity—Donepezil—Alzheimer's disease	0.0001	0.000499	CcSEcCtD
Paliperidone—Feeling abnormal—Rivastigmine—Alzheimer's disease	9.98e-05	0.000496	CcSEcCtD
Paliperidone—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	9.9e-05	0.000492	CcSEcCtD
Paliperidone—Urticaria—Memantine—Alzheimer's disease	9.83e-05	0.000489	CcSEcCtD
Paliperidone—Abdominal pain—Memantine—Alzheimer's disease	9.78e-05	0.000486	CcSEcCtD
Paliperidone—Body temperature increased—Memantine—Alzheimer's disease	9.78e-05	0.000486	CcSEcCtD
Paliperidone—Asthenia—Donepezil—Alzheimer's disease	9.78e-05	0.000486	CcSEcCtD
Paliperidone—Pruritus—Donepezil—Alzheimer's disease	9.64e-05	0.000479	CcSEcCtD
Paliperidone—Urticaria—Rivastigmine—Alzheimer's disease	9.62e-05	0.000478	CcSEcCtD
Paliperidone—Abdominal pain—Rivastigmine—Alzheimer's disease	9.57e-05	0.000476	CcSEcCtD
Paliperidone—Body temperature increased—Rivastigmine—Alzheimer's disease	9.57e-05	0.000476	CcSEcCtD
Paliperidone—Diarrhoea—Donepezil—Alzheimer's disease	9.32e-05	0.000464	CcSEcCtD
Paliperidone—Hypersensitivity—Memantine—Alzheimer's disease	9.12e-05	0.000453	CcSEcCtD
Paliperidone—Dizziness—Donepezil—Alzheimer's disease	9.01e-05	0.000448	CcSEcCtD
Paliperidone—Hypersensitivity—Rivastigmine—Alzheimer's disease	8.92e-05	0.000443	CcSEcCtD
Paliperidone—Asthenia—Memantine—Alzheimer's disease	8.88e-05	0.000441	CcSEcCtD
Paliperidone—Pruritus—Memantine—Alzheimer's disease	8.75e-05	0.000435	CcSEcCtD
Paliperidone—Asthenia—Rivastigmine—Alzheimer's disease	8.69e-05	0.000432	CcSEcCtD
Paliperidone—Vomiting—Donepezil—Alzheimer's disease	8.67e-05	0.000431	CcSEcCtD
Paliperidone—Rash—Donepezil—Alzheimer's disease	8.59e-05	0.000427	CcSEcCtD
Paliperidone—Dermatitis—Donepezil—Alzheimer's disease	8.59e-05	0.000427	CcSEcCtD
Paliperidone—Pruritus—Rivastigmine—Alzheimer's disease	8.56e-05	0.000426	CcSEcCtD
Paliperidone—Headache—Donepezil—Alzheimer's disease	8.54e-05	0.000424	CcSEcCtD
Paliperidone—Diarrhoea—Memantine—Alzheimer's disease	8.47e-05	0.000421	CcSEcCtD
Paliperidone—Diarrhoea—Rivastigmine—Alzheimer's disease	8.28e-05	0.000412	CcSEcCtD
Paliperidone—Dizziness—Memantine—Alzheimer's disease	8.18e-05	0.000407	CcSEcCtD
Paliperidone—Nausea—Donepezil—Alzheimer's disease	8.1e-05	0.000402	CcSEcCtD
Paliperidone—Dizziness—Rivastigmine—Alzheimer's disease	8.01e-05	0.000398	CcSEcCtD
Paliperidone—Vomiting—Memantine—Alzheimer's disease	7.87e-05	0.000391	CcSEcCtD
Paliperidone—Rash—Memantine—Alzheimer's disease	7.8e-05	0.000388	CcSEcCtD
Paliperidone—Dermatitis—Memantine—Alzheimer's disease	7.8e-05	0.000387	CcSEcCtD
Paliperidone—Headache—Memantine—Alzheimer's disease	7.75e-05	0.000385	CcSEcCtD
Paliperidone—Vomiting—Rivastigmine—Alzheimer's disease	7.7e-05	0.000383	CcSEcCtD
Paliperidone—Rash—Rivastigmine—Alzheimer's disease	7.63e-05	0.000379	CcSEcCtD
Paliperidone—Dermatitis—Rivastigmine—Alzheimer's disease	7.63e-05	0.000379	CcSEcCtD
Paliperidone—Headache—Rivastigmine—Alzheimer's disease	7.58e-05	0.000377	CcSEcCtD
Paliperidone—Nausea—Memantine—Alzheimer's disease	7.35e-05	0.000365	CcSEcCtD
Paliperidone—Nausea—Rivastigmine—Alzheimer's disease	7.19e-05	0.000357	CcSEcCtD
Paliperidone—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	3.8e-06	4.94e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	3.8e-06	4.94e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	3.79e-06	4.93e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	3.79e-06	4.93e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	3.78e-06	4.92e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	3.78e-06	4.91e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CASP3—Alzheimer's disease	3.78e-06	4.91e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.76e-06	4.89e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	3.76e-06	4.89e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—Alzheimer's disease	3.75e-06	4.88e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—F2—Alzheimer's disease	3.74e-06	4.87e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	3.74e-06	4.86e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	3.74e-06	4.86e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—F2—Alzheimer's disease	3.74e-06	4.86e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.72e-06	4.84e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	3.71e-06	4.82e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—INS—Alzheimer's disease	3.69e-06	4.8e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.69e-06	4.79e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	3.68e-06	4.78e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	3.68e-06	4.78e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.67e-06	4.77e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.67e-06	4.77e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	3.67e-06	4.77e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.66e-06	4.76e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.66e-06	4.75e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	3.64e-06	4.74e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.63e-06	4.71e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	3.62e-06	4.7e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.61e-06	4.69e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.61e-06	4.69e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	3.6e-06	4.68e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	3.59e-06	4.67e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.59e-06	4.66e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.58e-06	4.65e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	3.57e-06	4.64e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MAPK8—Alzheimer's disease	3.53e-06	4.58e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—AKT1—Alzheimer's disease	3.52e-06	4.57e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.51e-06	4.56e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	3.49e-06	4.54e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.47e-06	4.51e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MAPK8—Alzheimer's disease	3.47e-06	4.51e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	3.47e-06	4.51e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—AKT1—Alzheimer's disease	3.46e-06	4.5e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.45e-06	4.48e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.45e-06	4.48e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—INS—Alzheimer's disease	3.45e-06	4.48e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	3.44e-06	4.48e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.44e-06	4.47e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	3.43e-06	4.46e-05	CbGpPWpGaD
Paliperidone—DRD1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.43e-06	4.46e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	3.43e-06	4.45e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.41e-06	4.43e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.41e-06	4.43e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.4e-06	4.42e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	3.4e-06	4.42e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.39e-06	4.41e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	3.39e-06	4.41e-05	CbGpPWpGaD
Paliperidone—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	3.39e-06	4.4e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.38e-06	4.4e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—INS—Alzheimer's disease	3.38e-06	4.4e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	3.38e-06	4.39e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	3.37e-06	4.38e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.36e-06	4.36e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	3.35e-06	4.36e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	3.34e-06	4.34e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.34e-06	4.34e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	3.33e-06	4.33e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.33e-06	4.33e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	3.33e-06	4.33e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	3.33e-06	4.33e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.33e-06	4.33e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	3.33e-06	4.32e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	3.32e-06	4.32e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.29e-06	4.28e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.29e-06	4.28e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	3.28e-06	4.26e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	3.28e-06	4.26e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.27e-06	4.26e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.27e-06	4.25e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—VEGFA—Alzheimer's disease	3.26e-06	4.23e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.24e-06	4.21e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.23e-06	4.19e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.21e-06	4.18e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	3.2e-06	4.16e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.13e-06	4.07e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	3.12e-06	4.06e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	3.12e-06	4.05e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.1e-06	4.03e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	3.09e-06	4.01e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	3.08e-06	4.01e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	3.07e-06	4e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.06e-06	3.98e-05	CbGpPWpGaD
Paliperidone—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.06e-06	3.97e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	3.05e-06	3.97e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.04e-06	3.95e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	3.03e-06	3.94e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.02e-06	3.93e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	3.02e-06	3.93e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	3.01e-06	3.91e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.99e-06	3.88e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.99e-06	3.88e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.97e-06	3.87e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.97e-06	3.86e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.97e-06	3.85e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.96e-06	3.85e-05	CbGpPWpGaD
Paliperidone—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.95e-06	3.83e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	2.94e-06	3.82e-05	CbGpPWpGaD
Paliperidone—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.94e-06	3.82e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.92e-06	3.8e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.91e-06	3.79e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.91e-06	3.78e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.9e-06	3.77e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.89e-06	3.76e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.89e-06	3.75e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	2.88e-06	3.75e-05	CbGpPWpGaD
Paliperidone—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.86e-06	3.71e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	2.85e-06	3.7e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	2.83e-06	3.68e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.83e-06	3.67e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.82e-06	3.66e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	2.81e-06	3.65e-05	CbGpPWpGaD
Paliperidone—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.81e-06	3.65e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.8e-06	3.64e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.79e-06	3.63e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	2.78e-06	3.62e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.78e-06	3.62e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.78e-06	3.61e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	2.77e-06	3.59e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.71e-06	3.53e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.71e-06	3.52e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.69e-06	3.49e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.68e-06	3.48e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.67e-06	3.47e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.67e-06	3.46e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	2.65e-06	3.44e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	2.61e-06	3.4e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.6e-06	3.38e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.59e-06	3.37e-05	CbGpPWpGaD
Paliperidone—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.59e-06	3.37e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.57e-06	3.34e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.57e-06	3.34e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.56e-06	3.33e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.55e-06	3.32e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.55e-06	3.31e-05	CbGpPWpGaD
Paliperidone—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.55e-06	3.31e-05	CbGpPWpGaD
Paliperidone—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.54e-06	3.31e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.53e-06	3.28e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.52e-06	3.28e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	2.51e-06	3.27e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.51e-06	3.26e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.5e-06	3.25e-05	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.5e-06	3.24e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.48e-06	3.22e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.47e-06	3.21e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.47e-06	3.21e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	2.46e-06	3.2e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.46e-06	3.19e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.45e-06	3.19e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TP53—Alzheimer's disease	2.42e-06	3.15e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.41e-06	3.13e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—INS—Alzheimer's disease	2.4e-06	3.13e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.4e-06	3.12e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.4e-06	3.12e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.36e-06	3.07e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.36e-06	3.07e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.36e-06	3.07e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.35e-06	3.06e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.32e-06	3.02e-05	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.32e-06	3.01e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.32e-06	3.01e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.31e-06	3.01e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.31e-06	3e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	2.3e-06	2.99e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.3e-06	2.99e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.28e-06	2.97e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.28e-06	2.96e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.27e-06	2.95e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.27e-06	2.95e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.27e-06	2.94e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	2.25e-06	2.93e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—Alzheimer's disease	2.22e-06	2.88e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.2e-06	2.86e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.2e-06	2.85e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TP53—Alzheimer's disease	2.18e-06	2.83e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	2.18e-06	2.83e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.17e-06	2.82e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TP53—Alzheimer's disease	2.15e-06	2.8e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.14e-06	2.79e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.14e-06	2.78e-05	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	2.12e-06	2.76e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.11e-06	2.74e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.11e-06	2.74e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.11e-06	2.74e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.1e-06	2.73e-05	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	2.08e-06	2.7e-05	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	2.04e-06	2.66e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2e-06	2.6e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—Alzheimer's disease	2e-06	2.59e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.98e-06	2.57e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.97e-06	2.56e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.97e-06	2.56e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.96e-06	2.55e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.95e-06	2.53e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.94e-06	2.52e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.93e-06	2.51e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.93e-06	2.5e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.87e-06	2.44e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.86e-06	2.42e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.85e-06	2.4e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	1.84e-06	2.39e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.84e-06	2.39e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.83e-06	2.38e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.82e-06	2.37e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	1.82e-06	2.36e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.81e-06	2.36e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.79e-06	2.33e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.79e-06	2.32e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.78e-06	2.31e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.72e-06	2.23e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.71e-06	2.22e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.66e-06	2.16e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.65e-06	2.14e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.64e-06	2.13e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.63e-06	2.12e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.62e-06	2.1e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.62e-06	2.1e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.6e-06	2.08e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.59e-06	2.06e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.58e-06	2.06e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.57e-06	2.05e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—INS—Alzheimer's disease	1.57e-06	2.04e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.53e-06	1.99e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.51e-06	1.96e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.51e-06	1.96e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.49e-06	1.93e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.48e-06	1.93e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.48e-06	1.92e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.47e-06	1.91e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.45e-06	1.89e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.39e-06	1.81e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.38e-06	1.79e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.37e-06	1.78e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.36e-06	1.77e-05	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.36e-06	1.77e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.35e-06	1.75e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.34e-06	1.74e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.26e-06	1.64e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-06	1.62e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—AKT1—Alzheimer's disease	9.69e-07	1.26e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.34e-07	8.24e-06	CbGpPWpGaD
